Referred Tests
Leading
the way.
Testing developed
by neurologists for neurologists.
Neurology testing is rapidly evolving with increasing numbers of clinically relevant biomarkers discovered each year. Our laboratory collaborates closely with the practice and is designed to offer the most complex, clinically validated testing. Our disease experts support health care professionals in test selection and result interpretation to ensure proper test utilization and the highest quality of care. These physicians are committed to research and discovery to pave the way for the future of neurology testing.
Stay up-to-date on the latest discoveries and test launches. Sign up for our monthly neurology newsletter.
Results That Matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
400+
laboratory tests developed for our specialized neurology test menu
169
neurologists on staff at Mayo Clinic
19
testing laboratories performing
neurology testing
24/7
support from Mayo Clinic physicians and scientists
Advancing the
science
Novel biomarker discoveries occur at a rapid pace, and we are at the forefront of research that integrates these findings into our testing. We were the first laboratory to develop disease-specific evaluations, and our patient-care experience gives us the expertise to develop tests that deliver clinically relevant answers.
The largest neurology-specific test menu
Our highly specialized test menu provides answers for everything from the simplest to the most complex cases—and much of this testing is not available anywhere else.
Access to Mayo Clinic expertise
Our laboratories are led by clinical neurologists who have extensive experience in using testing to guide and directly impact patient care. These experts interpret each evaluation, providing clinically actionable answers, not just results.
New Testing for
Diagnosing Autoimmune Stiff-Person Syndrome
Mayo Clinic Laboratories launched glycine receptor antibody testing to complement antibody evaluations of GAD65-IgG and existing movement disorder panels to add to the overall accuracy of a diagnosis of autoimmune stiff-person syndrome.
The Latest
PACE / State of CA / State of FL
Originally presented January 14, 2021
This “Specialty Testing” webinar will discuss how hearing loss is diagnosed and how patient outcomes can be improved by genetic testing. Strategies for testing and confirming results will also be reviewed.
In this month’s “Hot Topic,” John Mills, Ph.D., explains the central role of tissue immunofluorescence in the identification of neural antibodies and discusses the benefits of an integrated laboratory approach to the development and validation of novel antibody biomarkers.
Developed with input from clinical specialists, the AudioloGene Hereditary Hearing Loss Panel offers the most comprehensive genetic assessment for hearing loss available today.
Nicole Boczek, Ph.D., co-director of Mayo Clinic's Genetics and Genomics Laboratory, explains the innovative new hereditary hearing loss panel now available through Mayo Clinic Laboratories. This comprehensive panel analyzes 160 genes associated with hereditary hearing loss, assessing for both nonsyndromic hearing loss, as well as syndromic hearing loss, which can be difficult to recognize clinically.
Dr. Bornhorst explains orexin testing's role in diagnosing type 1 narcolepsy and the significance of the test's availability through Mayo Clinic Laboratories.